Alpha Teknova, Inc. has grown revenue 3.7% a year over three years and 3.6% a year over five. Revenue growth, 3-year annual rate: +3.7% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +3.6%, growth has picked up over the last three years. Years of annual history on file: 6, FY2020 to FY2025, as filed.

TKNOAlpha Teknova, Inc.

Healthcare

$8.45+61% 1Y

$8.45

$1.9952 weeks$9.34

Is it growing?

Good

Growing: revenue growing +12% year on year and operating margin widening (+18.7 points).

2 good, 1 without data

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +4% a year.

Margin direction+18.7 points operating

Trailing-twelve-month operating margin, -36.8% now against -55.5% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is TKNO growing?

Alpha Teknova, Inc. has grown revenue 3.7% a year over three years and 3.6% a year over five.

+3.7%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +3.6%
Revenue growth, 5-year rate · +3.7% over three · growth has picked up over the last three years
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›